Human MutS homologue MSH4 physically interacts with von Hippel-Lindau tumor suppressor-binding protein 1

被引:0
|
作者
Her, C
Wu, XL
Griswold, MD
Zhou, F
机构
[1] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA
[2] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA
[3] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasing evidence indicated that the protein factors involved in DNA mismatch repair (MMR) possess meiotic functions beyond the scope of DNA mismatch correction. The important roles of MMR components in meiotic processes have been highlighted by the recent identification of two additional members of the mammalian MutS homologs, MSH4 and MSH5. Mammalian MSH4 and MSH5 proteins form a heterodimeric complex and play an important role in the meiotic processes. As a step forward to the understanding of the molecular mechanisms underlying the roles of these two mammalian MutS homologues, here we have identified von Hippel-Lindau (VHL) tumor suppressor-binding protein 1 (VBP1) as an interacting protein partner for human MSH4 (hMSH4). In addition, we have characterized a hMSH4 splicing variant (hMSH4sv) encoding a truncated form of hMSH4. The protein encoded by hMSH4sv was unable to interact with hMSH5, but it retained the capacity to interact with VBP1. It is conceivable that hMSH4 and hMSH4sv can carry out different but overlapping functions by differential protein interactions, and, therefore, bMSH4sv might represent a separation-of-function alternative form of the hMSH4 protein. hMSH4 and VBP1 proteins were colocalized in mammalian cells. Three-hybrid analysis suggested that VBP1 could compete with hMSH5 for the binding of hMSH4. Thus, hMSH4 may be involved in diverse cellular processes through interaction with different protein partners, and the levels of VBP1 protein expression in cells could potentially affect the availability of the hMSH4-hMSH5 hetero-complex.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 50 条
  • [21] IDENTIFICATION OF THE PROMOTER OF THE HUMAN VON HIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE
    KUZMIN, I
    DUH, FM
    LATIF, F
    GEIL, L
    ZBAR, B
    LERMAN, MI
    ONCOGENE, 1995, 10 (11) : 2185 - 2194
  • [22] Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1α eradicates gliomas
    Sun, X
    Liu, M
    Wei, Y
    Liu, F
    Zhi, X
    Xu, R
    Krissansen, GW
    CANCER GENE THERAPY, 2006, 13 (04) : 428 - 435
  • [23] Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1α eradicates gliomas
    X Sun
    M Liu
    Y Wei
    F Liu
    X Zhi
    R Xu
    G W Krissansen
    Cancer Gene Therapy, 2006, 13 : 428 - 435
  • [24] The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C
    Okuda, H
    Saitoh, K
    Hirai, S
    Iwai, K
    Takaki, Y
    Baba, M
    Minato, N
    Ohno, S
    Shuin, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) : 43611 - 43617
  • [25] Identification of Elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein
    Takagi, Y
    Pause, A
    Conaway, RC
    Conaway, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 27444 - 27449
  • [26] Role of exon 2-encoded β-domain of the von Hippel-Lindau tumor suppressor protein
    Bonicalzi, ME
    Groulx, I
    de Paulsen, N
    Lee, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) : 1407 - 1416
  • [27] Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein
    Esteban, Miguel A.
    Harten, Sarah K.
    Tran, Maxine G.
    Maxwell, Patrick H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07): : 1801 - 1806
  • [28] The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
    Ohh, M
    Yauch, RL
    Lonergan, KM
    Whaley, JM
    Stemmer-Rachamimov, AO
    Louis, DN
    Gavin, BJ
    Kley, N
    Kaelin, WG
    Iliopoulos, O
    MOLECULAR CELL, 1998, 1 (07) : 959 - 968
  • [29] New cancer targets emerging from studies of the Von Hippel-Lindau tumor suppressor protein
    Kaelin, William G., Jr.
    TOWARD PERSONALIZED MEDICINE FOR CANCER, 2010, 1210 : 1 - 7
  • [30] von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer
    Maynard, MA
    Ohh, M
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) : 1 - 13